BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 20513442)

  • 1. Butyrylcholinesterase as a therapeutic drug for protection against percutaneous VX.
    Lenz DE; Clarkson ED; Schulz SM; Cerasoli DM
    Chem Biol Interact; 2010 Sep; 187(1-3):249-52. PubMed ID: 20513442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and physiological effects of human butyrylcholinesterase as a post-exposure therapy against percutaneous poisoning by VX in the guinea-pig.
    Mumford H; Price ME; Cerasoli DM; Teschner W; Ehrlich H; Schwarz HP; Lenz DE
    Chem Biol Interact; 2010 Sep; 187(1-3):304-8. PubMed ID: 20176007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection against soman or VX poisoning by human butyrylcholinesterase in guinea pigs and cynomolgus monkeys.
    Lenz DE; Maxwell DM; Koplovitz I; Clark CR; Capacio BR; Cerasoli DM; Federko JM; Luo C; Saxena A; Doctor BP; Olson C
    Chem Biol Interact; 2005 Dec; 157-158():205-10. PubMed ID: 16289064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-exposure therapy with human butyrylcholinesterase following percutaneous VX challenge in guinea pigs.
    Mumford H; E Price M; Lenz DE; Cerasoli DM
    Clin Toxicol (Phila); 2011 Apr; 49(4):287-97. PubMed ID: 21563904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stoichiometric and catalytic scavengers as protection against nerve agent toxicity: a mini review.
    Lenz DE; Yeung D; Smith JR; Sweeney RE; Lumley LA; Cerasoli DM
    Toxicology; 2007 Apr; 233(1-3):31-9. PubMed ID: 17188793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylaxis with human serum butyrylcholinesterase protects guinea pigs exposed to multiple lethal doses of soman or VX.
    Saxena A; Sun W; Fedorko JM; Koplovitz I; Doctor BP
    Biochem Pharmacol; 2011 Jan; 81(1):164-9. PubMed ID: 20846507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-exposure therapy with recombinant human BuChE following percutaneous VX challenge in guinea-pigs.
    Mumford H; Troyer JK
    Toxicol Lett; 2011 Sep; 206(1):29-34. PubMed ID: 21620937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human plasma-derived BuChE as a stoichiometric bioscavenger for treatment of nerve agent poisoning.
    Mumford H; Docx CJ; Price ME; Green AC; Tattersall JE; Armstrong SJ
    Chem Biol Interact; 2013 Mar; 203(1):160-6. PubMed ID: 22981459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy studies of Reactive Skin Decontamination Lotion, M291 Skin Decontamination Kit, 0.5% bleach, 1% soapy water, and Skin Exposure Reduction Paste Against Chemical Warfare Agents, part 1: guinea pigs challenged with VX.
    Braue EH; Smith KH; Doxzon BF; Lumpkin HL; Clarkson ED
    Cutan Ocul Toxicol; 2011 Mar; 30(1):15-28. PubMed ID: 20942572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single treatment of VX poisoned guinea pigs with the phosphotriesterase mutant C23AL: Intraosseous versus intravenous injection.
    Wille T; Neumaier K; Koller M; Ehinger C; Aggarwal N; Ashani Y; Goldsmith M; Sussman JL; Tawfik DS; Thiermann H; Worek F
    Toxicol Lett; 2016 Sep; 258():198-206. PubMed ID: 27397758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioscavenger is effective as a delayed therapeutic intervention following percutaneous VX poisoning in the guinea-pig.
    Mann TM; Price ME; Whitmore CL; Perrott RL; Laws TR; McColm RR; Emery ER; Tattersall JEH; Green AC; Rice H
    Toxicol Lett; 2018 Sep; 293():198-206. PubMed ID: 29183815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-exposure treatment of VX poisoned guinea pigs with the engineered phosphotriesterase mutant C23: a proof-of-concept study.
    Worek F; Seeger T; Reiter G; Goldsmith M; Ashani Y; Leader H; Sussman JL; Aggarwal N; Thiermann H; Tawfik DS
    Toxicol Lett; 2014 Nov; 231(1):45-54. PubMed ID: 25195526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo characterization of recombinant human butyrylcholinesterase (Protexia) as a potential nerve agent bioscavenger.
    Cerasoli DM; Griffiths EM; Doctor BP; Saxena A; Fedorko JM; Greig NH; Yu QS; Huang Y; Wilgus H; Karatzas CN; Koplovitz I; Lenz DE
    Chem Biol Interact; 2005 Dec; 157-158():363-5. PubMed ID: 16429486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicokinetics of the nerve agent (+/-)-VX in anesthetized and atropinized hairless guinea pigs and marmosets after intravenous and percutaneous administration.
    van der Schans MJ; Lander BJ; van der Wiel H; Langenberg JP; Benschop HP
    Toxicol Appl Pharmacol; 2003 Aug; 191(1):48-62. PubMed ID: 12915103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Butyrylcholinesterase in guinea pig lung lavage: a novel biomarker to assess lung injury following inhalation exposure to nerve agent VX.
    Graham JR; Wright BS; Rezk PE; Gordon RK; Sciuto AM; Nambiar MP
    Inhal Toxicol; 2006 Jun; 18(7):493-500. PubMed ID: 16603480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of skin decontamination on the time window for effective treatment of percutaneous VX exposure.
    Joosen MJ; van den Berg RM; de Jong AL; van der Schans MJ; Noort D; Langenberg JP
    Chem Biol Interact; 2017 Apr; 267():48-56. PubMed ID: 26855350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The stoichiometry of protection against soman and VX toxicity in monkeys pretreated with human butyrylcholinesterase.
    Raveh L; Grauer E; Grunwald J; Cohen E; Ashani Y
    Toxicol Appl Pharmacol; 1997 Jul; 145(1):43-53. PubMed ID: 9221822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Median lethal dose determination for percutaneous exposure to soman and VX in guinea pigs and the effectiveness of decontamination with M291 SDK or SANDIA foam.
    Clarkson ED; Schulz SM; Railer RF; Smith KH
    Toxicol Lett; 2012 Aug; 212(3):282-7. PubMed ID: 22698813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical countermeasure against respiratory toxicity and acute lung injury following inhalation exposure to chemical warfare nerve agent VX.
    Nambiar MP; Gordon RK; Rezk PE; Katos AM; Wajda NA; Moran TS; Steele KE; Doctor BP; Sciuto AM
    Toxicol Appl Pharmacol; 2007 Mar; 219(2-3):142-50. PubMed ID: 17188727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimation of the upper limit of human butyrylcholinesterase dose required for protection against organophosphates toxicity: a mathematically based toxicokinetic model.
    Ashani Y; Pistinner S
    Toxicol Sci; 2004 Feb; 77(2):358-67. PubMed ID: 14600276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.